Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04156399 · ClinicalTrials.gov registry record · NA
Acupuncture for Adults With Sickle Cell Disease (SCD): A Feasibility Study
A NA study, sponsored by University of Illinois at Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04156399 is a NA study that was terminated before completion, run by University of Illinois at Chicago. The registered enrollment target is 6 participants.
The verdict
NCT04156399, a NA study, was terminated before completion, sponsored by University of Illinois at Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The investigators long-term goal is to demonstrate the effectiveness of acupuncture for the treatment of adults with chronic pain due to sickle cell disease (SCD), a debilitating pain syndrome characterized by acute and chronic pain. The objective of this study is to explore the feasibility and acceptability of acupuncture with adult patients with SCD. All participants will receive acupuncture treatments twice per week for 5 weeks. Subjects will complete measures at baseline and post-treatment, and a measure of study acceptability at post-treatment. The investigators will describe the procedures and potential challenges to implementing the acupuncture protocol, and expect to identify and rectify any procedural problems that subjects report regarding the 10-session study protocol.
Interventions
- OTHER Acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-01-15 |
| Est. Completion | 2020-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04156399
The ClinicalTrials.gov registry entry for NCT04156399 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acupuncture is the first listed.
NCT04156399 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04156399 about?
NCT04156399 is a clinical study titled "Acupuncture for Adults With Sickle Cell Disease (SCD): A Feasibility Study". The investigators long-term goal is to demonstrate the effectiveness of acupuncture for the treatment of adults with chronic pain due to sickle cell disease (SCD), a debilitating pain syndrome characterized by acute and chronic pain. The objective of this study is to explore the feasibility and acce...
What is the current status of trial NCT04156399?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2020-01-15. Estimated completion is 2020-03-15.
What interventions are being tested in trial NCT04156399?
The interventions under investigation include: Acupuncture (OTHER).
Who is sponsoring clinical trial NCT04156399?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.